Quantcast

Johnson & Johnson Articles

J&J Company to Pay $1.25 Million Over Expiration Dates J&J Company to Pay $1.25 Million Over Expiration Dates

The U.S. Food and Drug Administration (FDA) today announced that it has settled a civil penalty case against Johnson & Johnson company Advanced Sterilization Products (ASP). ASP has agreed to pay $1.25 million over misbranded products that it distributed. Two …

Johnson & Johnson to Pay $2.5 Billion Over Hip Replacements

In January of this year a class-action lawsuit against Johnson & Johnson began. The lawsuit revolved around the company’s 2010 recall of hip replacements and whether Johnson & Johnson subsidiary DePuy Orthopaedics knew that the devices could release small bits …

Johnson & Johnson to Pay $2.2 Billion Over Risperdal Claims Johnson & Johnson to Pay $2.2 Billion Over Risperdal Claims

The U.S. Department of Justice and the U.S. Food and Drug Administration (FDA) today announced that Janssen Pharmaceuticals has plead guilty over the misbranding of the drug Risperdal. Janssen and its company, Johnson & Johnson, will pay a total of …

Infant Motrin Recall For 200,000 Bottles

Nearly 200,000 bottles of Concentrated Motrin Infants’ Drops have been recalled due to plastic particles. According to the Motrin website, the medicine is used to reduce fever as well as relieve minor aches and pains related to the multiple ailments …

Infant Motrin Recall Due To Potential Plastic Contamination Still In Effect

Infant Motrin is being recalled this week and Johnson & Johnson has voluntarily pulled 200,000 bottles off the shelves due to the risk of contamination by plastic particles. The company first issued a notice back in September about the recall …

Hip Implants Trial Against Johnson & Johnson Begins

The first of many lawsuits filed against Johnson & Johnson over the company’s 2010 recall of hip replacements has begun in Los Angeles. According to a Reuters report, 66-year-old Loren Kransky is alleging that Johnson & Johnson subsidiary DePuy knew …

Diabetes Drug Approved by U.S. FDA Committee
· 1

A U.S. Food and Drug Administration (FDA) committee this week approved the drug canagliflozin for the treatment of adults with type 2 diabetes. The Endrocrinologic and Metabolic Drugs Advisory Committee of the FDA voted 10 to 5 to approve the …

Camp Baby: Did Costly Mistakes Hurt The Conference?

Today I ran across a Brandweek article that covered Johnson and Johnson’s latest social media attempt to reach and engage mom bloggers: a three day conference entitled “Camp Baby”.